Li Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Li Zhang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Jian Qin
Traditional Chinese Medicine Department, The Seventh Affiliated Hospital of Sun Yat-sen University
2 shared publications - Jin Zhao
Traditional Chinese Medicine Department, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China, China
2 shared publications - Taoli Liu
Traditional Chinese Medicine Department, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China, China
2 shared publications - Tingying Zhang
The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, P.R. China
2 shared publications - Bin Ke
Department of VIP Region, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
1 shared publication - Jia-Pan Sun1 shared publication
Latest Publications
- Open Access
- 6 September 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 21 (6) , 2304-2318
High-Density Lipoprotein Cholesterol and Nuclear Factor I A in Type 2 Diabetes and Mild Cognitive Impairment: biomarkers and mechanistic insights
Introduction: Type 2 diabetes (T2D) and mild cognitive impairment (MCI) are interrelated conditions that significantly impair quality of life. This study aimed to identify a feasible biomarker for assessing T2D-MCI risk and to evaluate a potential therapeutic strategy.Material and methods: We integrated data from the National Health and Nutrition Examination Survey (NHANES) with Mendelian randomization (MR) to investigate genetic causal relationships between T2D, MCI, and their shared biomarkers. Transcriptomic analysis identified T2D-associated genes. Clinical trials evaluated the short-term effects of modified fasting therapy (MFT) on glucose regulation and cognitive function. Cellular assays and patient samples validated key genes’ roles in biochemical markers and downstream pathways.Results: Among 6,356 T2D and 1,138 MCI subjects, vitamin D, high-density lipoprotein cholesterol (HDL-C), globulin, and creatinine were associated with both conditions. MR analysis showed that higher HDL-C levels reduced T2D risk (0.9059, 95% CI: 0.8666–0.9470) but increased MCI risk (OR = 1.0482, 95% CI: 1.0216–1.0755). Nuclear Factor I A (NFIA) was identified as a key HDL-C regulator. In a clinical cohort (17 T2D patients and 23 controls), MFT reduced body mass index fasting glucose, and HDL-C, increased NFIA expression, and improved Montreal Cognitive Assessment scores, especially in T2D-MCI patients. HDL-C rebounded at six months. In vitro, NFIA overexpression increased intracellular HDL-C and suppressed NF-κB signaling, while NFIA knockdown reduced APOA1 and APOE.Conclusions: HDL-C has divergent genetic effects on T2D and MCI. NFIA modulates HDL-C and NF-κB activity, supporting metabolic and cognitive improvements. Targeting NFIA through MFT may represent a promising strategy for T2D-MCI prevention and treatment.
- 6 September 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 21 (6) , 2304-2318
Open AccessHigh-Density Lipoprotein Cholesterol and Nuclear Factor I A in Type 2 Diabetes and Mild Cognitive Impairment: biomarkers and mechanistic insights
Introduction: Type 2 diabetes (T2D) and mild cognitive impairment (MCI) are interrelated conditions that significantly impair quality of life. This study aimed to identify a feasible biomarker for assessing T2D-MCI risk and to evaluate a potential therapeutic strategy.Material and methods: We integrated data from the National Health and Nutrition Examination Survey (NHANES) with Mendelian randomization (MR) to investigate genetic causal relationships between T2D, MCI, and their shared biomarkers. Transcriptomic analysis identified T2D-associated genes. Clinical trials evaluated the short-term effects of modified fasting therapy (MFT) on glucose regulation and cognitive function. Cellular assays and patient samples validated key genes’ roles in biochemical markers and downstream pathways.Results: Among 6,356 T2D and 1,138 MCI subjects, vitamin D, high-density lipoprotein cholesterol (HDL-C), globulin, and creatinine were associated with both conditions. MR analysis showed that higher HDL-C levels reduced T2D risk (0.9059, 95% CI: 0.8666–0.9470) but increased MCI risk (OR = 1.0482, 95% CI: 1.0216–1.0755). Nuclear Factor I A (NFIA) was identified as a key HDL-C regulator. In a clinical cohort (17 T2D patients and 23 controls), MFT reduced body mass index fasting glucose, and HDL-C, increased NFIA expression, and improved Montreal Cognitive Assessment scores, especially in T2D-MCI patients. HDL-C rebounded at six months. In vitro, NFIA overexpression increased intracellular HDL-C and suppressed NF-κB signaling, while NFIA knockdown reduced APOA1 and APOE.Conclusions: HDL-C has divergent genetic effects on T2D and MCI. NFIA modulates HDL-C and NF-κB activity, supporting metabolic and cognitive improvements. Targeting NFIA through MFT may represent a promising strategy for T2D-MCI prevention and treatment.
- Open Access
- 24 April 2025
- Published by Elsevier in Pharmacological Research - Modern Chinese Medicine
- Vol. 15
Caloric restriction combined with Linggui Zhugan Decoction improves palmitic acid-induced insulin resistance
- 24 April 2025
- Published by Elsevier in Pharmacological Research - Modern Chinese Medicine
- Vol. 15
Open AccessCaloric restriction combined with Linggui Zhugan Decoction improves palmitic acid-induced insulin resistance
- Open Access
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 3576030
Fasting Therapy Contributes to the Improvement of Endothelial Function and Decline in Vascular Injury‐Related Markers in Overweight and Obese Individuals via Activating Autophagy of Endothelial Progenitor Cells
Background. High body mass index‐ (BMI‐) related vascular injury contributes to the pathogenesis of the atherosclerotic cardiovascular disease (ASCVD). Rigorous calorie restriction is one of the major lifestyle interventions to reduce vascular risk in overweight or obese individuals. However, the effects of fasting therapy (FT) on vascular function and the mechanism are still unclear. This study was aimed to investigate the impacts of FT on endothelial function, arterial stiffness, and circulating arterial damage parameters in overweight and obese individuals and possible mechanism. Methods. Overweight and obese individuals participated in FT intervention (7‐day very low calorie diet). Arterial function including brachial arterial flow‐mediated dilation (FMD), brachial‐ankle pulse wave velocity (baPWV), vascular injury‐related markers including trimethylamine N‐oxide (TMAO), and leptin and endothelial microparticles (EMPs) were assessed. Endothelial progenitor cells (EPCs) of these participants were isolated and cultured to investigate EPCs function. mRFP‐GFP‐LC3 confocal microscopy scanning and western blot were carried out to determine autophagy. Results. After FT, body weight and BMI significantly decreased (81.76 ± 12.04 vs. 77.51 ± 12.06 kg, P < 0.01; 29.93 ± 2.82 vs. 28.47 ± 2.83 kg/m2, P < 0.01). FT remarkably improved FMD (5.26 ± 1.34 vs. 6.25 ± 1.60%, P = 0.01) while baPWV kept unchanged. TMAO and leptin levels decreased (3.96 ± 1.85 vs. 2.73 ± 1.33 μmol/L, P = 0.044; 6814 ± 2639 vs. 3563 ± 2668 μmol/L, P < 0.01). EMPs showed a decreased tendency. EPCs function was significantly improved, autophagy fluorescence intensity was enhanced, and the level of Beclin1, Atg5, LC3 II/I also increased after starvation in vitro, and the effects were blocked by autophagy inhibitor. Conclusions. Our present study demonstrated for the first time that FT markedly improves endothelial function and reduces the levels of arterial injury markers through improving EPCs function via activating autophagy. These findings provide a novel insight into FT as a lifestyle intervention strategy to promote the maintenance of vascular homeostasis in overweight or obese individuals. The trial was registered with ChiCTR1900024290.
- 1 January 2020
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 3576030
Open AccessFasting Therapy Contributes to the Improvement of Endothelial Function and Decline in Vascular Injury‐Related Markers in Overweight and Obese Individuals via Activating Autophagy of Endothelial Progenitor Cells
Background. High body mass index‐ (BMI‐) related vascular injury contributes to the pathogenesis of the atherosclerotic cardiovascular disease (ASCVD). Rigorous calorie restriction is one of the major lifestyle interventions to reduce vascular risk in overweight or obese individuals. However, the effects of fasting therapy (FT) on vascular function and the mechanism are still unclear. This study was aimed to investigate the impacts of FT on endothelial function, arterial stiffness, and circulating arterial damage parameters in overweight and obese individuals and possible mechanism. Methods. Overweight and obese individuals participated in FT intervention (7‐day very low calorie diet). Arterial function including brachial arterial flow‐mediated dilation (FMD), brachial‐ankle pulse wave velocity (baPWV), vascular injury‐related markers including trimethylamine N‐oxide (TMAO), and leptin and endothelial microparticles (EMPs) were assessed. Endothelial progenitor cells (EPCs) of these participants were isolated and cultured to investigate EPCs function. mRFP‐GFP‐LC3 confocal microscopy scanning and western blot were carried out to determine autophagy. Results. After FT, body weight and BMI significantly decreased (81.76 ± 12.04 vs. 77.51 ± 12.06 kg, P < 0.01; 29.93 ± 2.82 vs. 28.47 ± 2.83 kg/m2, P < 0.01). FT remarkably improved FMD (5.26 ± 1.34 vs. 6.25 ± 1.60%, P = 0.01) while baPWV kept unchanged. TMAO and leptin levels decreased (3.96 ± 1.85 vs. 2.73 ± 1.33 μmol/L, P = 0.044; 6814 ± 2639 vs. 3563 ± 2668 μmol/L, P < 0.01). EMPs showed a decreased tendency. EPCs function was significantly improved, autophagy fluorescence intensity was enhanced, and the level of Beclin1, Atg5, LC3 II/I also increased after starvation in vitro, and the effects were blocked by autophagy inhibitor. Conclusions. Our present study demonstrated for the first time that FT markedly improves endothelial function and reduces the levels of arterial injury markers through improving EPCs function via activating autophagy. These findings provide a novel insight into FT as a lifestyle intervention strategy to promote the maintenance of vascular homeostasis in overweight or obese individuals. The trial was registered with ChiCTR1900024290.